| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 86761 |
质粒以及慢病毒的基因过表达方法 |
1203 |
axc |
2024-12-13 |
| 86762 |
CRISPR KI技术构建基因过表达细胞株 |
461 |
axc |
2024-12-13 |
| 86763 |
CRISPRa系统构建基因过表达细胞株,CRISPRa技术优势 |
421 |
axc |
2024-12-13 |
| 86764 |
PB转座子系统构建基因过表达细胞,技术介绍 |
734 |
axc |
2024-12-13 |
| 86765 |
慢病毒介导的稳定细胞株构建流程 |
750 |
axc |
2024-12-13 |
| 86766 |
慢病毒载体介导过表达和敲低细胞株的建立 |
415 |
axc |
2024-12-13 |
| 86767 |
七肽DOTA-YLYEIAR,1262403-90-6 |
191 |
h |
2024-12-12 |
| 86768 |
DOTA-CH2-Ph-azide(HCl salt) |
228 |
h |
2024-12-12 |
| 86769 |
NOTA-PEG-TAT,大环配体NOTA-聚乙二醇-TAT |
170 |
h |
2024-12-12 |
| 86770 |
DOTA-Lys-Cys-Acid,1180007-00-4 |
182 |
h |
2024-12-12 |
| 86771 |
DOTA-NHS ester,CAS170908-81-3 |
187 |
h |
2024-12-12 |
| 86772 |
C18-PEG-Lactoferrin; 十八烷基-聚乙二醇-乳铁蛋白 |
383 |
kx |
2024-12-12 |
| 86773 |
C18-PEG-Glucose ;十八烷基-聚乙二醇-葡萄糖 |
215 |
kx |
2024-12-12 |
| 86774 |
C18-PEG-NPC ;十八烷基-聚乙二醇-NPC |
219 |
kx |
2024-12-12 |
| 86775 |
1262403-92-8,十三肽DOTA-LGEYGFQNALIVR |
176 |
h |
2024-12-12 |
| 86776 |
七肽DOTA-YLYEIAR,1262403-91-7 |
129 |
h |
2024-12-12 |
| 86777 |
C10-SS-PEG-DBCO |
136 |
kx |
2024-12-12 |
| 86778 |
Biotin-PEG-C14, 生物素聚乙二醇C14 |
119 |
kx |
2024-12-12 |
| 86779 |
NH2-PEG3400-C16 palmitic acid ,氨基-聚乙二醇-棕榈酸 |
146 |
kx |
2024-12-12 |
| 86780 |
NH2-PEG350-C16 palmitic acid ,氨基-聚乙二醇-棕榈酸 |
154 |
kx |
2024-12-12 |
| 86781 |
mPEG-se-se-C16 ,甲氧基-聚乙二醇-双硒键-棕榈酸 |
169 |
kx |
2024-12-12 |
| 86782 |
NHS-PEG-C16 ;棕榈酸PEG活性酯 |
130 |
kx |
2024-12-12 |
| 86783 |
Cholesterol-PEG-CY5 ,CLS-PEG-CY5 |
118 |
kx |
2024-12-12 |
| 86784 |
NH2-PEG3400-C18 Stearic Acid ;氨基-聚乙二醇-硬脂酸 |
131 |
kx |
2024-12-12 |
| 86785 |
NH2-PEG550-C18 Stearic Acid ;氨基-聚乙二醇-硬脂酸 |
115 |
kx |
2024-12-12 |
| 86786 |
C18-PEG-CY3 ;十八烷基-聚乙二醇-CY3 CY3-PEG-C18 |
140 |
kx |
2024-12-12 |
| 86787 |
C18-PEG-PCL ;十八烷基-聚乙二醇-聚己内酯 PCL-PEG-C18 |
256 |
kx |
2024-12-12 |
| 86788 |
DOTA-RGD,DOTA-ingr多肽 |
167 |
h |
2024-12-12 |
| 86789 |
Lysozyme-C18 Stearic Acid ;硬脂酸功能化溶菌酶 |
185 |
kx |
2024-12-12 |
| 86790 |
NOTA-TATE,NOTA偶联多肽 |
190 |
h |
2024-12-12 |
| 86791 |
DOTA-Ala-Ala-Tyr-COOH,DOTA-AAY-OH |
133 |
h |
2024-12-12 |
| 86792 |
C18-PEG-FA ;十八烷基-聚乙二醇-叶酸 ; FA-PEG-C18 |
198 |
kx |
2024-12-12 |
| 86793 |
大环双功能螯合剂DOTA-PEG-Irgd |
151 |
h |
2024-12-12 |
| 86794 |
C18-PEG-SH; 十八烷基-聚乙二醇-巯基 |
170 |
kx |
2024-12-12 |
| 86795 |
biotin-DOTA conjugate 生物素-大环化合物 |
132 |
h |
2024-12-12 |
| 86796 |
DOTA-PEG-CY7,大环化合物DOTA标记荧光染料 |
153 |
h |
2024-12-12 |
| 86797 |
C18-PEG-Heparin ;十八烷基-聚乙二醇-肝素 |
116 |
kx |
2024-12-12 |
| 86798 |
RGD-PEI,多肽修饰聚乙烯亚胺,聚乙烯亚胺PEI25000 |
228 |
h |
2024-12-12 |
| 86799 |
C18-PEG-HSA ;十八烷基-聚乙二醇-人血清白蛋白 |
149 |
kx |
2024-12-12 |
| 86800 |
DOTA-cyclo(RGDfK)acetate,CAS:909024-55-1 |
122 |
h |
2024-12-12 |
| 86801 |
C18-PEG-cRGD ;十八烷基-聚乙二醇-靶向穿膜肽 |
160 |
kx |
2024-12-12 |
| 86802 |
DOTA-Ala-Ala-COOH,DOTA-丙氨酸-丙氨酸-羧酸 |
100 |
h |
2024-12-12 |
| 86803 |
C18-PEG-Mannose ;十八烷基-聚乙二醇-甘露糖 |
119 |
|
2024-12-12 |
| 86804 |
c(RGD)环肽:DOTA-c(RGDfK) |
111 |
h |
2024-12-12 |
| 86805 |
C18-PEG-Alkyne; 十八烷基-聚乙二醇-炔基 |
133 |
kx |
2024-12-12 |